Common Contracts

5 similar Equity Distribution Agreement contracts by Edesa Biotech, Inc., BioXcel Therapeutics, Inc., Enveric Biosciences, Inc., iBio, Inc.

BioXcel Therapeutics, Inc. Common Stock (par value $0.001 per share) EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • April 3rd, 2025 • BioXcel Therapeutics, Inc. • Pharmaceutical preparations • New York
Enveric Biosciences, Inc. Common Stock (par value $0.01 per share) EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • September 1st, 2023 • Enveric Biosciences, Inc. • Pharmaceutical preparations • New York

Enveric Biosciences, Inc., a Delaware corporation (the “Company”), confirms this agreement (this “Agreement”) with Canaccord Genuity LLC (the “Manager”) as follows:

Edesa Biotech, Inc. Common Shares, without par value, Having an Aggregate Offering Price of up to US$20,000,000 EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • March 27th, 2023 • Edesa Biotech, Inc. • Pharmaceutical preparations • New York

Edesa Biotech, Inc., a company incorporated pursuant to the laws of the Province of British Columbia, Canada (the “Company”), confirms this agreement (this “Agreement”) with Canaccord Genuity LLC (the “Manager”) as follows:

Edesa Biotech, Inc. Common Shares, without par value, Having an Aggregate Offering Price of up to $15,000,000 USD EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • November 22nd, 2021 • Edesa Biotech, Inc. • Pharmaceutical preparations • New York
iBio, Inc. $45,000,000 Shares of Common Stock (par value $0.001 per share) EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • June 17th, 2020 • iBio, Inc. • Pharmaceutical preparations • New York

iBio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with UBS Securities LLC (the “Manager”), as follows: